Markou Kostas B, Paraskevopoulou Panagiota, Karaiskos Konstantinos S, Makri Maria, Georgopoulos Neoklis A, Iconomou Gregoris, Mengreli Chryssanthi, Vagenakis Apostolos G
Department of Medicine, Division of Endocrinology, University of Patras Medical School, University Hospital, Patras GR-26500, Greece.
J Clin Endocrinol Metab. 2003 Feb;88(2):617-21. doi: 10.1210/jc.2002-020681.
The aim of the present study was to examine the effects of chronic iodide administration in pharmacological doses on thyroid function in children with a history of transient congenital hypothyroidism (TCH). We hypothesized that such children may carry a previously undisclosed intrinsic intrathyroidal defect, rendering them susceptible to TCH. We administered for this 60-65 mg iodide daily for 60 d in 13 individuals with TCH (group A), 8 of their siblings (group B), 8 healthy controls (group C), and 11 normal adults (group D). Thyroid function was evaluated by measuring serum T(3), T(4), free T(3), free T(4), TSH, and thyroglobulin concentrations and autoantibodies against thyroid peroxidase and thyroglobulin at baseline at 15, 30, and 60 d during iodide administration, and 2 months after iodide withdrawal. Hyperthyrotropinemia greater than 4.2 mU/liter but not higher than 10 mU/liter with normal thyroid hormone concentrations was observed in one of the TCH group and in two of the group B siblings. During iodide administration, hyperthyrotropinemia was observed in 8 of 13 (62%) adolescents in group A, 4 of 7 (57%) in group B, and 6 of 8 (75%) in group C. None of the 11 adults (group D) developed hyperthyrotropinemia during iodide administration. Serum T(4) and free T(4) concentrations were decreased in all groups when compared with baseline values. The magnitude of the decrease of serum T(4) was identical in all groups (0.7-0.8 microg/dl). Thyroid enlargement was observed in all subjects and was more pronounced in children. There were no cases of subclinical and/or overt hyperthyroidism. After iodine withdrawal, serum TSH decreased in all groups and returned to baseline levels, as well as the thyroid volume. In conclusion, the hypothalamic-pituitary-thyroid axis of adolescents with TCH responds to pharmacological doses of iodide similarly to that observed in normal children. The hyperthyrotropinemia observed in the adolescents exposed to iodides may reflect incipient transient hypothyroidism or simply a brisk TSH response to a small serum T(4) decrease. Whatever the mechanism, chronic use of excessive quantities of iodide should be avoided until the end of puberty.
本研究的目的是探讨长期给予药理剂量的碘化物对有短暂性先天性甲状腺功能减退症(TCH)病史儿童甲状腺功能的影响。我们假设这类儿童可能存在先前未被发现的甲状腺内固有缺陷,使他们易患TCH。我们对13名TCH患儿(A组)、他们的8名兄弟姐妹(B组)、8名健康对照者(C组)和11名正常成年人(D组),每天给予60 - 65mg碘化物,持续60天。在给予碘化物的基线期、第15天、第30天和第60天以及停用碘化物2个月后,通过测量血清T(3)、T(4)、游离T(3)、游离T(4)、TSH和甲状腺球蛋白浓度以及抗甲状腺过氧化物酶和甲状腺球蛋白自身抗体来评估甲状腺功能。在TCH组中的1例和B组兄弟姐妹中的2例中观察到促甲状腺激素血症高于4.2mU/升但不高于10mU/升且甲状腺激素浓度正常。在给予碘化物期间,A组13名青少年中有8例(62%)、B组7名中有4例(57%)、C组8名中有6例(75%)观察到促甲状腺激素血症。11名成年人(D组)在给予碘化物期间均未出现促甲状腺激素血症。与基线值相比,所有组的血清T(4)和游离T(4)浓度均降低。所有组血清T(4)降低的幅度相同(0.7 - 0.8μg/dl)。所有受试者均观察到甲状腺肿大,在儿童中更为明显。没有亚临床和/或显性甲状腺功能亢进的病例。停用碘后,所有组的血清TSH均降低并恢复到基线水平,甲状腺体积也恢复到基线水平。总之,有TCH的青少年的下丘脑 - 垂体 - 甲状腺轴对药理剂量碘化物的反应与正常儿童相似。在接触碘化物的青少年中观察到的促甲状腺激素血症可能反映了初期短暂性甲状腺功能减退,或者仅仅是TSH对血清T(4)小幅下降的快速反应。无论机制如何,在青春期结束前应避免长期过量使用碘化物。